Concepedia
Statistics
Publications
8
Citations
330
H-Index
Active since
1980
Affiliations
University of Chicago(Current)
University of Washington
Keith L. Shulman is an author at University of Chicago specializing in medicine, oncology, and cancer immunotherapy.
Publications per year
1980–2003
Rituximab induces remission of cerebral ischemia caused by thrombotic thrombocytopenic purpura
Han‐Mou Tsai, Keith L. Shulman · European Journal Of Haematology · 2003 · 89 citations
Medicine, Hematology, Neurology +13
Prolonged continuous intravenous infusion interleukin-2 and lymphokine-activated killer-cell therapy for metastatic renal cell carcinoma.
John A. Thompson, Keith L. Shulman, Mark Benyunes et al. · Journal of Clinical Oncology · 1992 · 76 citations
Medicine, Immunology, Oncology +15
Breaststroker's knee: pathology, etiology, and treatment
S. David Stulberg, Keith L. Shulman, Steven Stuart et al. · The American Journal of Sports Medicine · 1980 · 52 citations
Medicine, Kinesiology, Orthopedic Biomechanics +5
Adverse Reactions to Intravenous Contrast Media in Patients Treated with Interleukin-2
Keith L. Shulman, John A. Thompson, Mark Benyunes et al. · Journal of Immunotherapy · 1993 · 51 citations
Medicine, Oncology, Radiology +16
Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced pancreatic carcinoma: A University of Chicago phase II consortium study
Sridhar Mani, J. W. Kugler, David F. Sciortino et al. · Annals of Oncology · 1998 · 17 citations · Full text
Medicine, Oncology, Pharmacology +8
1–5 of 8